-
Something wrong with this record ?
Alpha-tomatine activates cell cycle checkpoints in the absence of DNA damage in human leukemic MOLT-4 cells
Jana Kúdelová, Martina Seifrtová, Lenka Suchá, Pavel Tomšík, Radim Havelek, Martina Řezáčová
Language English Country Czech Republic
NLK
Free Medical Journals
from 2003 to 2013
Freely Accessible Science Journals
from 2003 to 2013
ROAD: Directory of Open Access Scholarly Resources
from 2002
- Keywords
- chk2, checkpoint kinase 2,
- MeSH
- Apoptosis drug effects MeSH
- Cell Death drug effects MeSH
- Comet Assay MeSH
- Leukemia, T-Cell * drug therapy MeSH
- Cell Line, Tumor MeSH
- Tumor Suppressor Protein p53 * analysis metabolism drug effects MeSH
- Oncogene Protein p21(ras) MeSH
- DNA Damage MeSH
- Cell Proliferation drug effects MeSH
- Protein Serine-Threonine Kinases metabolism MeSH
- Antineoplastic Agents MeSH
- Flow Cytometry MeSH
- Puma MeSH
- DNA Replication MeSH
- Statistics as Topic MeSH
- In Vitro Techniques MeSH
- Tomatine * analogs & derivatives therapeutic use MeSH
- Blotting, Western MeSH
Alpha-tomatine is a major glycoalkaloid found in the roots, leaves, stems and fruit of tomatoes Lycopersicon esculentum . Recently, alpha-tomatine has been recognized as a potential anticancer drug. In the present study, we identified the signaling cascades involved in the antitumor effect of alpha-tomatine on MOLT-4 leukemic cells. Alpha-tomatine inhibited the proliferation and decreased the viability of MOLT-4 cells in a dose-dependent manner. An increase in the activity of caspases 9 and 3/7 was not observed. However, an increase in the amount of p53 and its phosphorylation on serine 15, as well as an increased amount of mitochondrial protein PUMA was detected 4 and 24 h after exposure to alpha-tomatine at a concentration of 1–3 μmol/l. Inhibition of the proliferation of MOLT-4 cells by alpha-tomatine is also associated with an increase in p21 WAF1/CIP1 and the activation of Chk2. The comet assay did not detect significant amounts of single or double DNA strand breaks in cells treated with alpha-tomatine at concentrations of 0.1–9 μmol/l. Our results thus contribute to the understanding of the anticancer action of alpha-tomatine.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13028219
- 003
- CZ-PrNML
- 005
- 20131022101034.0
- 007
- ta
- 008
- 130902s2013 xr d f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.2478/v10136-012-0033-8 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kúdelová, Jana $7 _AN074460 $u Department of Medical Biochemistry, Charles University Prague, Faculty of Medicine, Hradec Králové
- 245 10
- $a Alpha-tomatine activates cell cycle checkpoints in the absence of DNA damage in human leukemic MOLT-4 cells / $c Jana Kúdelová, Martina Seifrtová, Lenka Suchá, Pavel Tomšík, Radim Havelek, Martina Řezáčová
- 504 __
- $a Literatura
- 520 9_
- $a Alpha-tomatine is a major glycoalkaloid found in the roots, leaves, stems and fruit of tomatoes Lycopersicon esculentum . Recently, alpha-tomatine has been recognized as a potential anticancer drug. In the present study, we identified the signaling cascades involved in the antitumor effect of alpha-tomatine on MOLT-4 leukemic cells. Alpha-tomatine inhibited the proliferation and decreased the viability of MOLT-4 cells in a dose-dependent manner. An increase in the activity of caspases 9 and 3/7 was not observed. However, an increase in the amount of p53 and its phosphorylation on serine 15, as well as an increased amount of mitochondrial protein PUMA was detected 4 and 24 h after exposure to alpha-tomatine at a concentration of 1–3 μmol/l. Inhibition of the proliferation of MOLT-4 cells by alpha-tomatine is also associated with an increase in p21 WAF1/CIP1 and the activation of Chk2. The comet assay did not detect significant amounts of single or double DNA strand breaks in cells treated with alpha-tomatine at concentrations of 0.1–9 μmol/l. Our results thus contribute to the understanding of the anticancer action of alpha-tomatine.
- 650 12
- $a tomatin $x analogy a deriváty $x terapeutické užití $7 D014053
- 650 _2
- $a poškození DNA $7 D004249
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a protinádorové látky $7 D000970
- 650 _2
- $a kometový test $7 D020552
- 650 12
- $a nádorový supresorový protein p53 $x analýza $x metabolismus $x účinky léků $7 D016159
- 650 12
- $a leukemie T-buněčná $x farmakoterapie $7 D015458
- 650 _2
- $a protein-serin-threoninkinasy $x metabolismus $7 D017346
- 650 _2
- $a replikace DNA $7 D004261
- 650 _2
- $a western blotting $7 D015153
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a statistika jako téma $7 D013223
- 650 _2
- $a buněčná smrt $x účinky léků $7 D016923
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a onkogenní protein p21(ras) $7 D015689
- 650 _2
- $a Puma $7 D046011
- 650 _2
- $a techniky in vitro $7 D066298
- 653 00
- $a chk2
- 653 00
- $a checkpoint kinase 2
- 700 1_
- $a Seifrtová, Martina $7 xx0134476 $u Department of Medical Biochemistry, Charles University Prague, Faculty of Medicine, Hradec Králové
- 700 1_
- $a Suchá, Lenka $7 _AN074461 $u Hradec Králové
- 700 1_
- $a Tomšík, Pavel, $d 1977- $7 xx0076495 $u Hradec Králové
- 700 1_
- $a Havelek, Radim $7 xx0230947 $u Hradec Králové
- 700 1_
- $a Řezáčová, Martina, $d 1972- $7 nlk20020124956 $u Hradec Králové
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 11, č. 2 (2013), s. 93-103 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2013/02/05.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 3 $z 0
- 990 __
- $a 20130902075546 $b ABA008
- 991 __
- $a 20131022101626 $b ABA008
- 999 __
- $a ok $b bmc $g 992243 $s 826651
- BAS __
- $a 3
- BMC __
- $a 2013 $b 11 $c 2 $i 1214-021X $m Journal of Applied Biomedicine $n J. Appl. Biomed. (Čes. Budějovice Print) $x MED00012667 $d 93-103
- LZP __
- $c NLK188 $d 20131022 $a NLK 2013-37/ip